{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:31:24Z","timestamp":1790973084019,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T00:00:00Z","timestamp":1676678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T00:00:00Z","timestamp":1676678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1038\/s41375-023-01845-9","type":"journal-article","created":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T17:09:56Z","timestamp":1676740196000},"page":"914-918","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study"],"prefix":"10.1038","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8746-9404","authenticated-orcid":false,"given":"Riccardo","family":"Bomben","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8438-1661","authenticated-orcid":false,"given":"Francesca Maria","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Vit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Bittolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Zucchetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robel","family":"Papotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Tissino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2986-7658","authenticated-orcid":false,"given":"Federico","family":"Pozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Degan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9381-1520","authenticated-orcid":false,"given":"Jerry","family":"Polesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Bulian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6431-6878","authenticated-orcid":false,"given":"Roberto","family":"Marasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4687-7089","authenticated-orcid":false,"given":"Gianluigi","family":"Reda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Laurenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Chiarenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Laureana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Postorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ilaria","family":"Del Principe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cuneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fortunato","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3722-553X","authenticated-orcid":false,"given":"Gilberto","family":"Fronza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Tafuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Zaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5021-3026","authenticated-orcid":false,"given":"Robin","family":"Fo\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Di Raimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Del Poeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5933-9680","authenticated-orcid":false,"given":"Valter","family":"Gattei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,18]]},"reference":[{"key":"1845_CR1","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3324\/haematol.2018.187583","volume":"103","author":"E Campo","year":"2018","unstructured":"Campo E, Cymbalista F, Ghia P, J\u00e4ger U, Pospisilova S, Rosenquist R, et al. TP53 aberrations in chronic lymphocytic leukemia: An overview of the clinical implications of improved diagnostics. Haematologica. 2018;103:1956\u201368.","journal-title":"Haematologica."},{"key":"1845_CR2","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1158\/1078-0432.CCR-20-4890","volume":"27","author":"C Brieghel","year":"2021","unstructured":"Brieghel C, Aarup K, Torp MH, Andersen MA, Yde CW, Tian X, et al. Clinical outcomes in patients with multi-hit TP53 chronic lymphocytic leukemia treated with ibrutinib. Clin Cancer Res. 2021;27:4531\u20138.","journal-title":"Clin Cancer Res"},{"key":"1845_CR3","doi-asserted-by":"publisher","first-page":"E306","DOI":"10.1002\/ajh.26235","volume":"96","author":"F Morabito","year":"2021","unstructured":"Morabito F, Del Poeta G, Mauro FR, Reda G, Sportoletti P, Laurenti L, et al. TP53 disruption as a risk factor in the era of targeted therapies: a multicenter retrospective study of 525 chronic lymphocytic leukemia cases. Am J Hematol. 2021;96:E306\u201310.","journal-title":"Am J Hematol"},{"key":"1845_CR4","doi-asserted-by":"publisher","first-page":"5566","DOI":"10.1158\/1078-0432.CCR-21-0701","volume":"27","author":"R Bomben","year":"2021","unstructured":"Bomben R, Rossi FM, Vit F, Bittolo T, D\u2019Agaro T, Zucchetto A, et al. TP53 mutations with low variant allele frequency predict short survival in Chronic Lymphocytic Leukemia. Clin Cancer Res. 2021;27:5566\u201376.","journal-title":"Clin Cancer Res"},{"key":"1845_CR5","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41375-017-0007-7","volume":"32","author":"J Malcikova","year":"2018","unstructured":"Malcikova J, Tausch E, Rossi D, Sutton LA, Soussi T, Zenz T, et al. ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia - Update on methodological approaches and results interpretation. Leukemia. 2018;32:1070\u201380.","journal-title":"Leukemia."},{"key":"1845_CR6","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1084\/jem.20171288","volume":"215","author":"E Tissino","year":"2018","unstructured":"Tissino E, Benedetti D, Herman SEM, ten Hacken E, Ahn IE, Chaffee KG, et al. Functional and clinical relevance of VLA-4 (CD49d\/CD29) in ibrutinib-treated chronic lymphocytic leukemia. J Exp Med. 2018;215:681\u201397.","journal-title":"J Exp Med"},{"key":"1845_CR7","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1200\/JCO.20.00979","volume":"39","author":"IE Ahn","year":"2021","unstructured":"Ahn IE, Tian X, Ipe D, Cheng M, Albitar M, Tsao LC, et al. Prediction of outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: development and validation of a four-factor prognostic model. J Clin Oncol. 2021;39:576\u201385.","journal-title":"J Clin Oncol"},{"key":"1845_CR8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ajh.26127","volume":"96","author":"F Morabito","year":"2021","unstructured":"Morabito F, Tripepi G, Del Poeta G, Mauro FR, Reda G, Sportoletti P, et al. Assessment of the 4-factor score: retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study. Am J Hematol. 2021;96:168\u201371.","journal-title":"Am J Hematol"},{"key":"1845_CR9","first-page":"0","volume":"10","author":"M Gentile","year":"2020","unstructured":"Gentile M, Martino EA, Visentin A, Coscia M, Reda G, Sportoletti P, et al. Validation of a survival-risk score (SRS) in relapsed\/refractory CLL patients treated with idelalisib\u2013rituximab. Blood. Cancer J. 2020;10:0\u20132.","journal-title":"Cancer J"},{"key":"1845_CR10","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.3324\/haematol.2021.280376","volume":"107","author":"AR Mato","year":"2022","unstructured":"Mato AR, Tang B, Azmi S, Yang K, Zhang X, Stern JC, et al. A clinical practice comparison of patients with chronic lymphocytic leukemia with and without deletion 17p receiving first-line treatment with ibrutinib. Haematologica 2022;107:2630\u201340.","journal-title":"Haematologica"},{"key":"1845_CR11","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1002\/ajh.26595","volume":"97","author":"HJ Cherng","year":"2022","unstructured":"Cherng HJ, Khwaja R, Kanagal-Shamanna R, Tang G, Burger J, Thompson P, et al. TP53-altered chronic lymphocytic leukemia treated with firstline Bruton\u2019s tyrosine kinase inhibitor-based therapy: a retrospective analysis. Am J Hematol. 2022;97:1005\u201312.","journal-title":"Am J Hematol"},{"key":"1845_CR12","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1182\/blood.2020009530","volume":"138","author":"J Malcikova","year":"2021","unstructured":"Malcikova J, Pavlova S, Kunt Vonkova B, Radova L, Plevova K, Kotaskova J, et al. Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options. Blood. 2021;138:2670\u201385.","journal-title":"Blood."},{"key":"1845_CR13","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1182\/blood.2020010536","volume":"138","author":"AS Kittai","year":"2021","unstructured":"Kittai AS, Miller C, Goldstein D, Huang Y, Abruzzo LV, Beckwith K, et al. The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinib. Blood. 2021;138:2372\u201382.","journal-title":"Blood."},{"key":"1845_CR14","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3324\/haematol.2020.263715","volume":"107","author":"L Cafforio","year":"2022","unstructured":"Cafforio L, Raponi S, Cappelli LV, Ilari C, Soscia R, De Propris MS, et al. Treatment with ibrutinib does not induce a TP53 clonal evolution in chronic lymphocytic leukemia. Haematologica. 2022;107:334\u20137.","journal-title":"Haematologica."},{"key":"1845_CR15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1182\/bloodadvances.2016003632","volume":"1","author":"S Kadri","year":"2017","unstructured":"Kadri S, Lee J, Fitzpatrick C, Galanina N, Sukhanova M, Venkataraman G, et al. Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL. Blood Adv. 2017;1:715\u201327.","journal-title":"Blood Adv"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-01845-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-01845-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-01845-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T11:08:38Z","timestamp":1680779318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-01845-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,18]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1845"],"URL":"https:\/\/doi.org\/10.1038\/s41375-023-01845-9","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,18]]},"assertion":[{"value":"12 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}